CrossrefInfokarte
Sequential ICI plus Anti-VEGF/TKI with On-Demand TACE beyond RECIST Progression Improves Pathological Response, Resectability, and Survival in Unresectable HCC
Liver Cancer · 2026-03-05 · 15 (2) · 169-177
DOI: 10.1159/000551332 ↗Abstract
Kein Abstract verfügbar.
EUVIMED